Results 91 to 100 of about 3,220,539 (261)

Design, synthesis and biological evaluation of novel epigenetic modulators for parasitic diseases [PDF]

open access: yes, 2017
Current therapies for human parasite infections rely on a few drugs, most of which have severe side effects, and their usefulness is being seriously threatened by the drug resistance problem.
HAILU, GEBREMEDHIN SOLOMON
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Construction of a tumor-associated myeloid cell infiltration signature model based on LASSO-Cox regression for predicting postoperative overall survival in patients with gastric cancer

open access: yesZhongguo Linchuang Yixue
ObjectiveTo explore the impact of tumor-associated myeloid cell infiltration signatures on postoperative overall survival (OS) in patients with gastric cancer. MethodsA retrospective analysis was performed on patients who underwent radical gastrectomy at
Leihao Wang   +5 more
doaj   +1 more source

Protein biomarkers of external root resorption: A new protein extraction protocol. Are we going in the right direction?

open access: yesDental Press Journal of Orthodontics, 2014
OBJECTIVE: The aim of this study is to determine a protocol of gingival crevicular fluid protein extraction used for the first dimension of 2-DE gels.
Giovanni Modesto Vieira
doaj   +1 more source

Molecular Markers in Plants

open access: yes, 2013
Molecular Markers in Plants surveys an array of technologies used in the molecular analysis of plants. The role molecular markers play in plant improvement has grown significantly as DNA sequencing and high-throughput technologies have matured.
Henry, Robert J.
core  

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

External Debt and Growth Dynamics [PDF]

open access: yes, 2006
Based on an extended growth model, this thesis further explores the joint dynamics between external debt and growth. The model explicitly expresses this growth dynamic mechanism incorporating external debt as an important explanatory variable with risk ...
CHEN, Si
core  

External Audit from Quality Perspective

open access: yes, 2019
This Chapter gives the definition of external audit, types of it, and displays the importance of external audit under quality control perspective title.
Kesimli, İffet Görkey
core   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy